Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Haleon Plc (HLN)

Haleon Plc (HLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 38,218,684
  • Shares Outstanding, K 4,566,151
  • Annual Sales, $ 14,059 M
  • Annual Income, $ 1,305 M
  • 60-Month Beta 0.28
  • Price/Sales 2.73
  • Price/Cash Flow 22.75
  • Price/Book 1.85
Trade HLN with:

Options Overview Details

View History
  • Implied Volatility 43.17% ( +5.88%)
  • Historical Volatility 15.63%
  • IV Percentile 80%
  • IV Rank 38.25%
  • IV High 103.17% on 04/18/24
  • IV Low 6.01% on 09/01/23
  • Put/Call Vol Ratio 0.31
  • Today's Volume 46
  • Volume Avg (30-Day) 44
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 3,470
  • Open Int (30-Day) 3,151

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.08
  • Growth Rate Est. (year over year) +1,248,650.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.06 +5.58%
on 04/18/24
8.64 -1.45%
on 04/30/24
+0.40 (+4.93%)
since 04/17/24
3-Month
7.89 +7.86%
on 03/18/24
8.69 -2.01%
on 03/12/24
+0.29 (+3.53%)
since 02/16/24
52-Week
7.70 +10.59%
on 11/02/23
8.96 -5.02%
on 07/28/23
-0.15 (-1.73%)
since 05/17/23

Most Recent Stories

More News
1 Pharma Stock to Buy Near 52-Week Highs

GSK's stock has been a poor performer for years. But recently, the pharma stock keeps setting new 52-week highs, thanks to its blockbuster vaccines.

GSK : 44.98 (+0.22%)
HLN : 8.51 (+1.67%)
1 Pharma Stock to Buy on Strong Vaccine Growth Potential

Unlike many of its peers, GSK just reported a big year-over-year jump in vaccine sales - and there's more growth to come, as the pharmaceutical company expands both its pipeline and the geographical reach...

MRNA : 132.90 (+0.17%)
GSK : 44.98 (+0.22%)
HLN : 8.51 (+1.67%)
CVS : 57.68 (+0.28%)
An Under the Radar Healthcare Stock to Add to Your Portfolio

The era of the giant pharmaceutical conglomerate is coming to a close, but consumer-focused Haleon stock looks set to deliver healthy returns through long-term economic cycles.

HLN : 8.51 (+1.67%)
GSK : 44.98 (+0.22%)
PFE : 28.64 (-0.97%)
NVS : 102.57 (-0.12%)
Is GSK Stock Worth Buying Right Now?

GSK stock could be a bargain.

HLN : 8.51 (+1.67%)
GSK : 44.98 (+0.22%)
Voltaren Partners with Fitness Instructor and TV Personality Amanda Kloots to Help Caregivers Discover the Joy of Movement

/PRNewswire/ -- More than 53 million Americans provide care to family members or loved ones,1 but an overwhelming 4 out of 5 Americans say that pain has...

HLN : 8.51 (+1.67%)
Stocks Climb Before the Open as Investors Weigh Economic Outlook, U.S. JOLTs Report in Focus

June S&P 500 futures (ESM23) are up +0.29%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.61% this morning after three major U.S. benchmark indices finished the regular session mixed as weaker-than-expected...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
TSLA : 177.46 (+1.50%)
VORB : 0.0769 (-34.83%)
OKYO.LN : 1.400 (-24.32%)
BFLY : 1.0300 (+1.98%)
AMC : 4.40 (-5.17%)
ONCT : 8.66 (-1.87%)
EVO : 5.25 (-4.37%)
HLN : 8.51 (+1.67%)
CRBG : 31.30 (-3.72%)
GSK's New Drugs and Pipeline Hold the Key to Growth in 2023

GSK's specialty products like Dovato, Nucala, Trelegy Ellipta and Shingrix are likely to drive sales, making up for the lower sales of established drugs due to generic erosion.

GSK : 44.98 (+0.22%)
ANIK : 25.40 (-0.39%)
SNDX : 20.29 (-3.01%)
HLN : 8.51 (+1.67%)
GSK's Q3 Earnings Beat, Ups 2022 Sales Outlook, Stock Up

GSK's (GSK) revenues benefit from the strong growth in sales across all segments. The company raises the full-year sales guidance for all its segment

GSK : 44.98 (+0.22%)
JNJ : 154.64 (+0.23%)
PFE : 28.64 (-0.97%)
HLN : 8.51 (+1.67%)
Haleon plc Announces Expiration and Results of Exchange Offers for Certain Series of Notes Issued in Private Placements in Connection with the Separation from GSK

Not for release, publication or distribution, directly or indirectly, in or into any jurisdiction into which such distribution would be unlawful. This notice...

HLN : 8.51 (+1.67%)
Should Investors Bite Into Dan Loeb’s Latest Target?

Activist investor Dan Loeb has taken a nearly $1 stake in Colgate-Palmolive. He wants the company to unload its pet food business. 

CL : 94.13 (-0.42%)
HLN : 8.51 (+1.67%)
GSK : 44.98 (+0.22%)
PFE : 28.64 (-0.97%)
JNJ : 154.64 (+0.23%)
PG : 167.64 (-0.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Haleon plc engages in the research and development, manufacture and sale of various consumer healthcare products principally in North America, Europe, the Middle East, Africa, Latin America and the Asia Pacific. It provides therapeutic oral health, pain relief, respiratory health, digestive health and...

See More

Key Turning Points

3rd Resistance Point 8.69
2nd Resistance Point 8.60
1st Resistance Point 8.56
Last Price 8.51
1st Support Level 8.43
2nd Support Level 8.34
3rd Support Level 8.30

See More

52-Week High 8.96
Last Price 8.51
Fibonacci 61.8% 8.48
Fibonacci 50% 8.33
Fibonacci 38.2% 8.18
52-Week Low 7.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar